Human Tumor Immunology at the Molecular Divide

Abstract

In the mid-1980s, as a young investigator at Duke University running a human immunology laboratory with interest in T cell allograft rejection, I was becoming very confident in my ability to grow human alloreactive T cell lines from small biopsies of kidney allografts and use them to define their Ag